Novartis AG
NVS
$112.12
$0.240.22%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.57% | 2.49% | |||
| Total Other Revenue | 16.05% | -3.06% | |||
| Total Revenue | 2.93% | 2.33% | |||
| Cost of Revenue | 2.25% | 2.27% | |||
| Gross Profit | 3.15% | 2.35% | |||
| SG&A Expenses | 11.78% | 1.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 1,300.00% | 214.29% | |||
| Total Operating Expenses | 8.40% | 2.23% | |||
| Operating Income | -7.94% | 2.53% | |||
| Income Before Tax | -2.95% | -11.87% | |||
| Income Tax Expenses | 132.50% | -66.39% | |||
| Earnings from Continuing Operations | -11.46% | -1.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -150.00% | -- | |||
| Net Income | -11.63% | -1.76% | |||
| EBIT | -7.94% | 2.53% | |||
| EBITDA | -24.45% | 2.78% | |||
| EPS Basic | -10.52% | -0.73% | |||
| Normalized Basic EPS | -2.63% | 3.29% | |||
| EPS Diluted | -10.08% | -1.26% | |||
| Normalized Diluted EPS | -2.75% | 3.18% | |||
| Average Basic Shares Outstanding | -1.24% | -1.03% | |||
| Average Diluted Shares Outstanding | -1.13% | -0.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
